May 14, 2026 — CSL, a global leader in developing lifesaving protein biotherapies for people with rare and serious diseases, is continuing to evolve its digital and customer engagement transformation across its commercial and medical operations. As part of this effort, today we announced that CSL is expanding its collaboration with Salesforce, including its use of Agentforce Life Sciences for Customer Engagement, an integrated and AI-powered platform that supports more connected, insight-driven engagement across its global operations.
This marks a significant expansion of CSL’s existing Salesforce footprint. CSL Plasma, the company’s plasma collection business, already uses Data 360 to unify data across donor experiences and is deploying Agentforce in its donor contact center to enhance service delivery. The new implementation will extend these capabilities across CSL’s commercial organization, including the company’s vaccines business, Seqirus, creating a more unified view of customers and enabling more coordinated, data-driven engagement across the company.
The platform will support CSL’s efforts to better connect data, enhance field engagement, and enable more personalized and coordinated experiences across the customer journey.
